More on VERA
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $35.45 |
|
|||
| Open | $35.45 | ||||
| 52 Wk High | $1.18 | ||||
| 52 Wk Low | $0.36 | ||||
| Day High | $35.45 | ||||
| Day Low | $35.45 | ||||
| P/E | 590.83 | ||||
| EPS | $0.06 | ||||
| Volume | 1 | ||||
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Form 4 Vera Therapeutics, Inc. For: Jul 07 Filed by: Fordyce Marshall
- Vera Therapeutics names Nancy Boman as chief regulatory officer
- Form 8-K Vera Therapeutics, Inc. For: Jul 09
- Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner
- Vera Therapeutics (VERA) PT Raised to $78 at TD Cowen
- Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald on Trutakna Approval
- Vera Therapeutics (VERA) PT Raised to $76 at Guggenheim
- Vera Therapeutics (VERA) PT Raised to $125 at H.C. Wainwright
- Form 8-K Vera Therapeutics, Inc. For: Jul 07
Entities mentioned with VERA
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Cowen & Co | View Related Stories »
- JPMorgan | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Show More...
